Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20
What Is The Future Market Size Estimation For The In Vitro Diagnostic (IVD) In Cardiology And Neurology Market Covering 2025–2034?
The in vitro diagnostic (ivd) in cardiology and neurology market has experienced substantial growth in recent years. This market is forecast to increase from $15.84 billion in 2024 to $17.22 billion in 2025, at a compound annual growth rate (CAGR) of 8.7%. The expansion observed in the past can be attributed to several factors, including a rise in the occurrence of age-related cardiovascular and neurological conditions, an increasing elderly demographic, a greater emphasis on preventive healthcare and early disease detection, the escalating burden of cardiovascular diseases (CVDs) and neurological disorders such as stroke and Alzheimer’s disease, an increase in investments within healthcare infrastructure, and the development of supportive regulatory frameworks governing the approval and reimbursement of diagnostic tests.
The in vitro diagnostic (ivd) in cardiology and neurology market is poised for substantial expansion in the upcoming years, with projections indicating growth to $23.59 billion by 2029, exhibiting a compound annual growth rate (CAGR) of 8.2%. This growth during the forecast period can be attributed to factors such as a move towards personalized medicine in cardiology and neurology, increasing demand for rapid and localized testing solutions in these fields, the broadening scope of telemedicine and remote consultation services, and a rise in research initiatives. Major trends anticipated in this period encompass the emergence of liquid biopsy technologies, advancements in nanotechnology, the adoption of remote monitoring devices like implantable cardiac monitors and brain-computer interfaces, the utilization of multiplex biomarker panels, innovations in medical imaging modalities such as MRI, CT, and PET scans, and the development of companion diagnostics for cardiovascular and neurological drugs.
Unlock Your Free Sample Report for Exclusive Market Data:
https://www.thebusinessresearchcompany.com/sample.aspx?id=15829&type=smp
Which Drivers Are Supporting Growth Of The In Vitro Diagnostic (IVD) In Cardiology And Neurology Market?
The growing prevalence of personalized medicine is projected to propel the expansion of the in vitro diagnostic (IVD) in cardiology and neurology market in the future. Personalized medicine is defined as a healthcare strategy that customizes medical choices, procedures, treatments, and interventions based on the unique attributes of each patient. The rise of personalized medicine is attributed to factors such as progress in genomics, enhanced comprehension of disease processes, patient desire for customized therapies, and backing from regulatory bodies. In cardiology and neurology, in vitro diagnostic (IVD) tests support personalized medicine by delivering vital data concerning a person’s genetic profile and disease condition, thereby informing individualized treatment strategies for better effectiveness and lower risks. As an illustration, the Personalized Medicine Coalition, a US-based professional membership organization, reported that in 2022, the approval of 12 new personalized medicines constituted roughly 34% of all recently approved therapies, showing a significant rise compared to prior years. Consequently, the rising volume of personalized medicines is boosting the expansion of the in vitro diagnostic (IVD) in cardiology and neurology market.
What Are The Major Segments Identified In The In Vitro Diagnostic (IVD) In Cardiology And Neurology Market?
The in vitro diagnostic (ivd) in cardiology and neurologymarket covered in this report is segmented –
1) By Product Type: Instruments; Reagents And Consumables; Software And Services
2) By Technology: Immunoassays; Molecular Diagnostics; Hematology; Other Technologies
3) By End-User: Hospitals; Clinical Laboratories; Other End-Users
Subsegments:
1) By Instruments: Diagnostic Analyzers; Point-Of-Care Devices; Electrophysiology Devices
2) By Reagents And Consumables: Diagnostic Reagents; Test Kits; Assay Consumables
3) By Software And Services: Diagnostic Software; Data Management Software; IVD Consulting And Support Services
Which Key Trends Are Expected To Influence The In Vitro Diagnostic (IVD) In Cardiology And Neurology Market In The Coming Years?
Companies active in the in vitro diagnostic (IVD) in cardiology and neurology market are concentrating on the creation of AI-enabled integrated epigenetic engines, aimed at early disease detection and risk evaluation. These AI-enabled integrated epigenetic engines utilize machine-learning models and sophisticated biomarker analysis techniques to improve the sensitivity and accuracy in the diagnosis and monitoring of cardiovascular diseases, thereby tackling critical factors driving disease progression. As an illustration, in February 2023, US-based biotechnology company Cardio Diagnostics Holdings Inc. introduced PrecisionCHD, an AI-based blood test specifically for the early identification of coronary heart disease (CHD). Employing the company’s integrated epigenetic-genetic engine, this test assesses CHD risk and seeks to prevent and detect the most prevalent form of cardiovascular disease. The new test incorporates epigenetic and genetic biomarkers with machine-learning algorithms, providing over 75% sensitivity for both men and women. It connects a patient’s biomarker profile to modifiable risk factors such as smoking, diabetes, hypertension, and high cholesterol, which are significant contributors to CHD. PrecisionCHD serves as a non-invasive alternative to exercise stress tests or angiograms, with blood samples able to be collected in-office or at home.
Which Major Firms Are Strengthening Their Position In The In Vitro Diagnostic (IVD) In Cardiology And Neurology Industry?
Major companies operating in the in vitro diagnostic (IVD) in cardiology and neurology market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Siemens Healthineers AG, Becton Dickinson And Company, Quest Diagnostics Incorporated, Hologic Inc., Illumina Inc., Beckman Coulter Inc., Quidel Corporation, Sysmex Corporation, Bio-Rad Laboratories Inc., QIAGEN N.V., Instrumentation Laboratory, bioMérieux SA, Natera, Inc., Randox Laboratories Ltd., Fulgent Genetics Inc., DiaSorin S.p.A., Oxford Nanopore Technologies, Fujirebio Diagnostics Inc., Adaptive Biotechnologies, Biocartis Group NV, Agena Bioscience
Download The Full Report For Exclusive Market Findings:
How Does The In Vitro Diagnostic (IVD) In Cardiology And Neurology Market Perform Across Key Geographic Regions?
North America was the largest region in the in vitro diagnostic (IVD) in cardiology and neurology market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the in vitro diagnostic (IVD) in cardiology and neurology market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Customized Version Of The In Vitro Diagnostic (IVD) In Cardiology And Neurology Market Report:
https://www.thebusinessresearchcompany.com/customise?id=15829&type=smp
Browse Through More Reports Similar to the Global In Vitro Diagnostic (IVD) In Cardiology And Neurology Market 2025, By The Business Research Company
In Vitro Diagnostics Ivd Quality Control Global Market Report 2025
In Vitro Toxicology Testing Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/in-vitro-toxicology-testing-global-market-report
In Vitro Diagnostics Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/in-vitro-diagnostics-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model